{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "binds",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ07398",
      "entity_text" : "GRP78--a",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ07384",
      "entity_text" : "SP94",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "CellLine" : [ "cellosaurus:CVCL_0027" ],
      "Cellular_component" : [ "go:GO:0016020" ],
      "Species" : [ "taxonomy:10090" ]
    }
  },
  "verbose_text" : "Having verified that SP94 specifically binds GRP78--a marker of HCC, we developed a novel nanocaged drug carrier HccFn-Dox nanocages suitable to specifically kill HCC tumor cells.",
  "reading_complete" : "2020-08-02T16:52:33Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T16:51:18Z",
  "trigger" : "binds",
  "evidence" : [ "SP94 specifically binds GRP78--a" ],
  "pmc_id" : "6531302",
  "score" : 0
}